|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts: $375 for each period | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Note receivable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Current assets held for sale, discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Noncurrent assets: | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right-of-use asset | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Inventory, non-current | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Intangible assets, in-process research and development | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Noncurrent assets of discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Accrued protocol expense | ||||||||||||||||||||
| Accrued radioactive waste disposal | ||||||||||||||||||||
| Accrued payroll and related taxes | ||||||||||||||||||||
| Accrued vacation | ||||||||||||||||||||
| Accrued personnel expenses | ||||||||||||||||||||
| Note payable | ||||||||||||||||||||
| Deferred Income (Note 3) | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Noncurrent liabilities: | ||||||||||||||||||||
| Lease liability, net of current portion | ||||||||||||||||||||
| Note payable, net of current portion | ||||||||||||||||||||
| Asset retirement obligation | ||||||||||||||||||||
| Noncurrent liabilities of discontinued operations | ||||||||||||||||||||
| Deferred Income (Note 3) | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock: $0.001 par value; 7,000,000 shares authorized; 5,000,000 designatedSeries B convertible; no shares issued | ||||||||||||||||||||
| Common stock: $0.001 par value; 750,000,000 shares authorized; 114,086,092 and 74,337,990 shares issued | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
